Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.02
INFU's Cash to Debt is ranked lower than
100% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.75 vs. INFU: 0.02 )
Ranked among companies with meaningful Cash to Debt only.
INFU' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.1 Max: No Debt
Current: 0.02
Equity to Asset 0.53
INFU's Equity to Asset is ranked lower than
61% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. INFU: 0.53 )
Ranked among companies with meaningful Equity to Asset only.
INFU' s Equity to Asset Range Over the Past 10 Years
Min: 0.51  Med: 0.56 Max: 0.73
Current: 0.53
0.51
0.73
Interest Coverage 6.68
INFU's Interest Coverage is ranked lower than
80% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 39.93 vs. INFU: 6.68 )
Ranked among companies with meaningful Interest Coverage only.
INFU' s Interest Coverage Range Over the Past 10 Years
Min: 0.6  Med: 1.61 Max: 6.68
Current: 6.68
0.6
6.68
F-Score: 5
Z-Score: 1.42
M-Score: -2.23
WACC vs ROIC
3.11%
6.24%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 11.19
INFU's Operating margin (%) is ranked higher than
67% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.16 vs. INFU: 11.19 )
Ranked among companies with meaningful Operating margin (%) only.
INFU' s Operating margin (%) Range Over the Past 10 Years
Min: -121.45  Med: 9.47 Max: 14.03
Current: 11.19
-121.45
14.03
Net-margin (%) 6.02
INFU's Net-margin (%) is ranked higher than
59% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.53 vs. INFU: 6.02 )
Ranked among companies with meaningful Net-margin (%) only.
INFU' s Net-margin (%) Range Over the Past 10 Years
Min: -83.17  Med: 1.99 Max: 28.12
Current: 6.02
-83.17
28.12
ROE (%) 9.09
INFU's ROE (%) is ranked higher than
63% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.61 vs. INFU: 9.09 )
Ranked among companies with meaningful ROE (%) only.
INFU' s ROE (%) Range Over the Past 10 Years
Min: -72.53  Med: -0.63 Max: 13.38
Current: 9.09
-72.53
13.38
ROA (%) 4.76
INFU's ROA (%) is ranked higher than
62% of the 202 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.66 vs. INFU: 4.76 )
Ranked among companies with meaningful ROA (%) only.
INFU' s ROA (%) Range Over the Past 10 Years
Min: -43.99  Med: -0.42 Max: 8.56
Current: 4.76
-43.99
8.56
ROC (Joel Greenblatt) (%) 21.45
INFU's ROC (Joel Greenblatt) (%) is ranked higher than
67% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.27 vs. INFU: 21.45 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
INFU' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -319.11  Med: 21.21 Max: 117.01
Current: 21.45
-319.11
117.01
Revenue Growth (3Y)(%) 4.80
INFU's Revenue Growth (3Y)(%) is ranked higher than
50% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. INFU: 4.80 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
INFU' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 5.2 Max: 88.1
Current: 4.8
0
88.1
EBITDA Growth (3Y)(%) 14.90
INFU's EBITDA Growth (3Y)(%) is ranked higher than
71% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.90 vs. INFU: 14.90 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
INFU' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -10.2  Med: 14.9 Max: 18
Current: 14.9
-10.2
18
» INFU's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-11-12)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q3 2015

INFU Guru Trades in Q3 2015

Mario Gabelli 28,980 sh (unchged)
Jim Simons Sold Out
» More
Q4 2015

INFU Guru Trades in Q4 2015

Jim Simons 14,600 sh (New)
Mario Gabelli 28,980 sh (unchged)
» More
Q1 2016

INFU Guru Trades in Q1 2016

Jim Simons 83,600 sh (+472.60%)
Mario Gabelli 28,980 sh (unchged)
» More
Q2 2016

INFU Guru Trades in Q2 2016

Jim Simons 160,000 sh (+91.39%)
Mario Gabelli 28,980 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with INFU

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:NAS:PLSE, NAS:EKSO, AMEX:MLSS, NAS:LENS, NAS:LAKE, NAS:HNSN, OTCPK:TSNLF, AMEX:RVP, OTCPK:PSDLF, NAS:CASM, NAS:BIOL, AMEX:ISR, OTCPK:TDMMF, NAS:HBIO, NAS:ATEC, AMEX:DXR, NAS:BLFS, OTCPK:BMRA, AMEX:BVX, NAS:DXTR » details
InfuSystems Holdings Inc is a provider of ambulatory infusion pumps and related services in the United States. It provides services to hospitals, oncology practices and facilities and other alternate site health care providers.

InfuSystems Holdings Inc a Delaware corporation was formed on August 15, 2005. The Company is a provider of infusion pumps and related services in the United States. It provides its services to hospitals, oncology practices and facilities and other alternate site health care providers. The Company delivers local, field-based customer support, and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada. Its core service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics to be utilized in the treatment of a variety of cancers including colorectal cancer. The Company provides these pumps and related supplies to oncology clinics, obtain an assignment of insurance benefits from the patient, and bill the patient's insurance company or patient as appropriate, for the use of the pump and supplies, and collect payment. It also provide pump management services for the pumps and associated disposable supply kits to approximately 1,800 oncology clinics in the United States, while retaining title to the pumps during this process. The competition is composed of regional DME providers, hospital-owned DME providers, physician providers and home care infusion providers. The operations complies with applicable federal, state and local environmental laws.

Ratios

vs
industry
vs
history
P/E(ttm) 14.46
INFU's P/E(ttm) is ranked higher than
84% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.11 vs. INFU: 14.46 )
Ranked among companies with meaningful P/E(ttm) only.
INFU' s P/E(ttm) Range Over the Past 10 Years
Min: 2.76  Med: 26.64 Max: 178
Current: 14.46
2.76
178
PE(NRI) 14.46
INFU's PE(NRI) is ranked higher than
83% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.42 vs. INFU: 14.46 )
Ranked among companies with meaningful PE(NRI) only.
INFU' s PE(NRI) Range Over the Past 10 Years
Min: 2.76  Med: 26.64 Max: 178
Current: 14.46
2.76
178
P/B 1.16
INFU's P/B is ranked higher than
79% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.07 vs. INFU: 1.16 )
Ranked among companies with meaningful P/B only.
INFU' s P/B Range Over the Past 10 Years
Min: 0.33  Med: 0.85 Max: 1.96
Current: 1.16
0.33
1.96
P/S 0.81
INFU's P/S is ranked higher than
81% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.01 vs. INFU: 0.81 )
Ranked among companies with meaningful P/S only.
INFU' s P/S Range Over the Past 10 Years
Min: 0.36  Med: 0.96 Max: 6.21
Current: 0.81
0.36
6.21
POCF 12.27
INFU's POCF is ranked higher than
65% of the 101 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.48 vs. INFU: 12.27 )
Ranked among companies with meaningful POCF only.
INFU' s POCF Range Over the Past 10 Years
Min: 2.39  Med: 6.2 Max: 13.39
Current: 12.27
2.39
13.39
EV-to-EBIT 11.78
INFU's EV-to-EBIT is ranked higher than
79% of the 117 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.49 vs. INFU: 11.78 )
Ranked among companies with meaningful EV-to-EBIT only.
INFU' s EV-to-EBIT Range Over the Past 10 Years
Min: -114.9  Med: 11.8 Max: 664.8
Current: 11.78
-114.9
664.8
EV-to-EBITDA 8.45
INFU's EV-to-EBITDA is ranked higher than
77% of the 132 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.12 vs. INFU: 8.45 )
Ranked among companies with meaningful EV-to-EBITDA only.
INFU' s EV-to-EBITDA Range Over the Past 10 Years
Min: -3.9  Med: 8 Max: 19.4
Current: 8.45
-3.9
19.4
Current Ratio 1.72
INFU's Current Ratio is ranked lower than
71% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.49 vs. INFU: 1.72 )
Ranked among companies with meaningful Current Ratio only.
INFU' s Current Ratio Range Over the Past 10 Years
Min: 0.01  Med: 1.32 Max: 483.08
Current: 1.72
0.01
483.08
Quick Ratio 1.57
INFU's Quick Ratio is ranked lower than
54% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.66 vs. INFU: 1.57 )
Ranked among companies with meaningful Quick Ratio only.
INFU' s Quick Ratio Range Over the Past 10 Years
Min: 0.01  Med: 1.22 Max: 483.08
Current: 1.57
0.01
483.08
Days Inventory 32.15
INFU's Days Inventory is ranked higher than
93% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 124.07 vs. INFU: 32.15 )
Ranked among companies with meaningful Days Inventory only.
INFU' s Days Inventory Range Over the Past 10 Years
Min: 14.99  Med: 28.54 Max: 41.01
Current: 32.15
14.99
41.01
Days Sales Outstanding 81.06
INFU's Days Sales Outstanding is ranked lower than
75% of the 167 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.94 vs. INFU: 81.06 )
Ranked among companies with meaningful Days Sales Outstanding only.
INFU' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.96  Med: 52.81 Max: 349.58
Current: 81.06
42.96
349.58
Days Payable 82.31
INFU's Days Payable is ranked higher than
69% of the 162 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 50.53 vs. INFU: 82.31 )
Ranked among companies with meaningful Days Payable only.
INFU' s Days Payable Range Over the Past 10 Years
Min: 40.19  Med: 75.79 Max: 242.43
Current: 82.31
40.19
242.43

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -1.10
INFU's 3-Year Average Share Buyback Ratio is ranked higher than
63% of the 131 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.70 vs. INFU: -1.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
INFU' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -74.2  Med: -3.35 Max: -0.2
Current: -1.1
-74.2
-0.2

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 2.91
INFU's Price/Tangible Book is ranked higher than
60% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.28 vs. INFU: 2.91 )
Ranked among companies with meaningful Price/Tangible Book only.
INFU' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.07  Med: 2.88 Max: 10.33
Current: 2.91
1.07
10.33
Price/Projected FCF 1.99
INFU's Price/Projected FCF is ranked lower than
54% of the 89 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.95 vs. INFU: 1.99 )
Ranked among companies with meaningful Price/Projected FCF only.
INFU' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.29  Med: 0.83 Max: 2.19
Current: 1.99
0.29
2.19
Price/Median PS Value 0.85
INFU's Price/Median PS Value is ranked higher than
74% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.17 vs. INFU: 0.85 )
Ranked among companies with meaningful Price/Median PS Value only.
INFU' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.38  Med: 1.05 Max: 5.15
Current: 0.85
0.38
5.15
Price/Graham Number 1.36
INFU's Price/Graham Number is ranked higher than
74% of the 88 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.50 vs. INFU: 1.36 )
Ranked among companies with meaningful Price/Graham Number only.
INFU' s Price/Graham Number Range Over the Past 10 Years
Min: 0.73  Med: 1.78 Max: 3.63
Current: 1.36
0.73
3.63
Earnings Yield (Greenblatt) (%) 8.54
INFU's Earnings Yield (Greenblatt) (%) is ranked higher than
87% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.80 vs. INFU: 8.54 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
INFU' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.2  Med: 7.7 Max: 30.8
Current: 8.54
0.2
30.8

More Statistics

Revenue (TTM) (Mil) $76.34
EPS (TTM) $ 0.19
Beta0.19
Short Percentage of Float1.51%
52-Week Range $2.34 - 3.75
Shares Outstanding (Mil)22.63
» More Articles for INFU

Headlines

Articles On GuruFocus.com
Meson Capital 2Q Letter Aug 19 2015 
Applying Buffett’s Arbitrage Techniques to Infusystem Jul 31 2013 
InfuSystem Buyout Coming with 32% Upside Potential Jul 22 2013 

More From Other Websites
INFUSYSTEM HOLDINGS, INC Financials Aug 19 2016
InfuSystem Holdings, Inc. :INFU-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 Aug 11 2016
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 10 2016
InfuSystem Holdings, Inc. Reports Second Quarter 2016 Financial Results Aug 10 2016
InfuSystem Holdings, Inc. Reports Second Quarter 2016 Financial Results Aug 10 2016
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 03 2016
InfuSystem To Issue Second Quarter 2016 Financial Results On Wednesday, August 10, 2016 Aug 03 2016
InfuSystem To Issue Second Quarter 2016 Financial Results On Wednesday, August 10, 2016 Aug 03 2016
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jul 29 2016
InfuSystem Holdings, Inc. Announces Resignation Of Chief Financial Officer And Replacements Jul 29 2016
InfuSystem Holdings, Inc. Announces Resignation Of Chief Financial Officer And Replacements Jul 29 2016
InfuSystem Holdings, Inc.: Gathering momentum, can it sustain its performance? Jul 07 2016
ETF’s with exposure to InfuSystem Holdings, Inc. : July 7, 2016 Jul 07 2016
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Other Events Jun 02 2016
InfuSystem Announces Two Long-Term Payor Agreements Jun 01 2016
InfuSystem Announces Two Long-Term Payor Agreements Jun 01 2016
InfuSystem Holdings, Inc. :INFU-US: Earnings Analysis: Q1, 2016 By the Numbers May 17 2016
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 10 2016
InfuSystem Holdings, Inc. Reports First Quarter 2016 Financial Results May 10 2016
InfuSystem Holdings, Inc. Reports First Quarter 2016 Financial Results May 10 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)